How is the Jenburkt Pharmaceuticals Ltd. today?

The Jenburkt Pharmaceuticals Ltd. today is trading in the down by -1.53% at 1003.65.

How has Jenburkt Pharmaceuticals Ltd. performed historically?

The Jenburkt Pharmaceuticals Ltd. is currently trading down -1.53% on an intraday basis in the past week the index fell -2.37%. The index has been down -7.88% in the past quarter and rose 25.63% in the past year. You can view this in the overview section.

What is Jenburkt Pharmaceuticals Ltd. Annual Revenue?

Jenburkt Pharmaceuticals Ltd. Annual Revenue rose 3.36%, in the last year to ₹146.63 Cr. Its sector's average revenue growth for the last fiscal year was 12.15%.

What is Jenburkt Pharmaceuticals Ltd. Annual Net Profit?

Jenburkt Pharmaceuticals Ltd. Annual Net Profit rose 5.57% in the last year to ₹25.98 Cr. Its sector's average net profit growth for the last fiscal year was 25.09%.

What is Jenburkt Pharmaceuticals Ltd. Price to Earning Ratio?

Jenburkt Pharmaceuticals Ltd. Price to Earning Ratio is 14.1, lower than its sector PE ratio of 40.13.

What is Jenburkt Pharmaceuticals Ltd. Stock Price?

Jenburkt Pharmaceuticals Ltd. Stock Price rose 25.63% and outperformed its sector by 7.42% in the past year.

What is Jenburkt Pharmaceuticals Ltd. Quarterly Revenue?

Jenburkt Pharmaceuticals Ltd. Quarterly Revenue rose 3.46% YoY to ₹38.47 Cr. Its sector's average revenue growth YoY for the quarter was 11.34%.

What is Jenburkt Pharmaceuticals Ltd. Quarterly Net profit?

Jenburkt Pharmaceuticals Ltd. Quarterly Net profit rose 20.41% YoY to ₹6.51 Cr. Its sector's average net profit growth YoY for the quarter was 31.58%.

What is Jenburkt Pharmaceuticals Ltd. Debt to Equity Ratio?

Jenburkt Pharmaceuticals Ltd. Debt to Equity Ratio is zero as the company is debt-free.

What is Jenburkt Pharmaceuticals Ltd. Return on Equity(ROE)?

Jenburkt Pharmaceuticals Ltd. Return on Equity(ROE) for the last financial year was 17.92%, in the normal range of 10% to 20%.

What is Jenburkt Pharmaceuticals Ltd. Mutual Fund Holding?

Jenburkt Pharmaceuticals Ltd. Mutual Fund Holding remained the same in the last quarter at 0%.

What is Jenburkt Pharmaceuticals Ltd. Promoter Share Holding?

Jenburkt Pharmaceuticals Ltd. Promoter Share Holding decreased by 0.01% in the most recent quarter to 46.68%.

What is Jenburkt Pharmaceuticals Ltd. Interest Coverage Ratio?

Jenburkt Pharmaceuticals Ltd. Interest Coverage Ratio is 139.59, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Jenburkt Pharmaceuticals Ltd. Promoter Pledges?

Jenburkt Pharmaceuticals Ltd. Promoter Pledges are zero.

Jenburkt Pharmaceuticals Ltd. BSE: 524731

Jenburkt Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Name: Jenburkt Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Jenburkt Pharmaceuticals Ltd.
Rating: 2.803791625
Author: Trendlyne DVM scores

Mid-range Performer

about

Jenburkt Pharmaceuticals in dealing of Pharmaceutical products.

1003.65 -15.60 (-1.53%)

27.01% Fall from 52W High

426 BSE Volume

BSE 09 May, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

High Financial Strength

70.0 / 100

Mid Valuation

47.8 / 100

Technically Neutral

36.5 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

No estimates available

Jenburkt Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Jenburkt Pharmaceuticals in dealing of Pharmaceutical products.

27.01% Fall from 52W High

SWOT Analysis

Jenburkt Pharmaceuticals Ltd. Live Price Chart

Earnings Conference Calls, Investor Presentations and Annual Reports

Annual Reports

Jenburkt Pharmaceuticals Ltd. FAQ

How is Jenburkt Pharmaceuticals Ltd. today?

Jenburkt Pharmaceuticals Ltd. today is trading in the red, and is down by -1.53% at 1003.65.

How has Jenburkt Pharmaceuticals Ltd. performed historically?

Jenburkt Pharmaceuticals Ltd. is currently trading down -1.53% on an intraday basis. In the past week the stock fell -2.37%. stock has been down -7.88% in the past quarter and rose 25.63% in the past year. You can view this in the overview section.